Log In
Print
BCIQ
Print
Print this Print this
 

Epidiolex, cannabidiol

  Manage Alerts
Collapse Summary General Information
Company GW Pharmaceuticals plc
DescriptionOral liquid formulation of cannabidiol, a phytocannabinoid found in Cannabis sativa
Molecular Target Cannabinoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationEpilepsy
Indication DetailsTreat Dravet syndrome; Treat Lennox-Gastaut syndrome (LGS); Treat treatment-resistant epilepsy
Regulatory Designation

U.S. - Fast Track (Treat Dravet syndrome);
U.S. - Orphan Drug (Treat Dravet syndrome);
U.S. - Orphan Drug (Treat Lennox-Gastaut syndrome (LGS));
EU - Orphan Drug (Treat Dravet syndrome)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today